CUSIP 04272N102COMAVBPQ4 2025
23 filings · latest Mar 5, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Infinitum Asset Management, LLC | 4.12M | $82.97M |
| 2 | Suvretta Capital Management, LLC | 4.11M | $82.61M |
| 3 | Hhlr Advisors, Ltd. | 3.93M | $79.05M |
| 4 | Fmr LLC | 3.70M | $74.52M |
| 5 | Orbimed Advisors LLC | 3.03M | $60.91M |
| 6 | Blackrock, Inc. | 2.37M | $47.74M |
| 7 | Octagon Capital Advisors LP | 1.97M | $39.66M |
| 8 | Novo Holdings A/S | 1.94M | $39.08M |
| 9 |
| 4 | Jan 30, 2026 | The Vanguard Group | 13G/A | 4.5% | 1.87M | SEC |
| 5 | Jan 21, 2026 | Blackrock, Inc. | 13G | 5.6% | 2.32M | SEC |
| 6 | Nov 14, 2025 | Octagon Capital Advisors LP | 13G/A | 4.9% | 1.97M | SEC |
| 7 | Nov 5, 2025 | Fmr LLC | 13G/A | 8.4% | 3.41M | SEC |
| 8 | Oct 30, 2025 | The Vanguard Group | 13G | 5.0% | 2.03M | SEC |
| 9 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 4.9% | 2.01M | SEC |
| 10 | Oct 15, 2025 | Hbm Healthcare Investments (Cayman) Ltd. | 13G | 5.4% | 2.20M | SEC |
See the full Schedule 13D/13G history for Arrivent Biopharma Inc.
Unlock full history| 1.87M |
| $37.61M |
| 10 | Sofinnova Investments, Inc. | 1.70M | $34.14M |